Pharmaceutical patent analyst : Impact Factor & More
eISSN: 2046-8962pISSN: 2046-8954
Share this on:
Key Metrics
CiteScore 
3.7
H-Index
19
SJR
Q3Drug Discovery
SNIP
7.18
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Pharmaceutical patent analyst
Pharmaceutical patent analyst Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | NEWLANDS PRESS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pharmaceutical patent analyst ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Pharmaceutical patent analyst
Trispecific anti-CLDN-18.2/CD3/CD28 antibodies for gastric cancer treatment.
- 5 Aug 2025
- Pharmaceutical patent analyst
Bispecific anti-CD38/CD28 antibodies for treatment of multiple myeloma.
- 22 Jul 2025
- Pharmaceutical patent analyst
Trivalent bispecific anti-MSLN2/CD3 antibody for cancer treatment.
- 22 Jul 2025
- Pharmaceutical patent analyst
Proteolysis targeting chimeras (PROTACs) in oncology: a review of patents and regulatory considerations.
- 15 May 2025
- Pharmaceutical patent analyst
Development in medicinal chemistry via oxadiazole derivatives: patent spotlight 2020-2024.
- 7 May 2025
- Pharmaceutical patent analyst
Patent highlights June - July 2024.
- 7 Mar 2025
- Pharmaceutical patent analyst
Trispecific anti-CLDN-18.2/CD3/CD28 antibodies for gastric cancer treatment.
- 5 Aug 2025
- Pharmaceutical patent analyst
Bispecific anti-CD38/CD28 antibodies for treatment of multiple myeloma.
- 22 Jul 2025
- Pharmaceutical patent analyst
Trivalent bispecific anti-MSLN2/CD3 antibody for cancer treatment.
- 22 Jul 2025
- Pharmaceutical patent analyst
Proteolysis targeting chimeras (PROTACs) in oncology: a review of patents and regulatory considerations.
- 15 May 2025
- Pharmaceutical patent analyst
Development in medicinal chemistry via oxadiazole derivatives: patent spotlight 2020-2024.
- 7 May 2025
- Pharmaceutical patent analyst
Patent highlights June - July 2024.
- 7 Mar 2025
- Pharmaceutical patent analyst
FAQs on Pharmaceutical patent analyst
How long has Pharmaceutical patent analyst been actively publishing? 
What is the publishing frequency of Pharmaceutical patent analyst?
How many articles did Pharmaceutical patent analyst publish last year?
What is the eISSN & pISSN for Pharmaceutical patent analyst?
What is Citescore for Pharmaceutical patent analyst?
What is the H Index for Pharmaceutical patent analyst ?
What is SNIP score for Pharmaceutical patent analyst?
What is the SJR for Pharmaceutical patent analyst?
Who is the publisher of Pharmaceutical patent analyst?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations